MyAverix Finance
SHG · Healthcare
Sinocelltech Group Ltd (688520)
Biotechnology
Sinocelltech Group Ltd (688520) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $18.46B, P/E ratio is 18.00, net margin is -35.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688520
Sinocelltech Group Ltd (688520) — FAQ
What is Sinocelltech Group Ltd's market cap?
Sinocelltech Group Ltd (688520) has a reported market cap of $18.46B (data as of 2026-03-29).
What is 688520's P/E ratio?
The price-to-earnings (P/E) ratio for Sinocelltech Group Ltd (688520) is 18.00 (data as of 2026-03-29).
Does Sinocelltech Group Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Sinocelltech Group Ltd (688520). Check the MyAverix Finance app for the latest dividend data.
What sector is Sinocelltech Group Ltd in?
Sinocelltech Group Ltd (688520) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688520 listed on?
688520 is listed on SHG.
What is Sinocelltech Group Ltd's net margin?
Sinocelltech Group Ltd (688520) reports a net margin of -35.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.